Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Eckstein, Anja
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study	Active, not recruiting	4	313	Europe, US	Teprotumumab, TEPEZZA, Placebo, Saline Solution	Amgen	Thyroid Eye Disease	04/26	04/26
NCT03865160: Low-dose Atropine for Myopia Control in Children	Recruiting	2/3	300	Europe	Atropine eye drops, 0.01%, Atropine eye drops, 0.02%, Placebo (NaCl 0.9%) eye drops	University Eye Hospital, Freiburg	Myopia, Progressive	10/25	04/26